InvestSMART

Nova Eye Medical Limited (ASX: EYE) - Announcements

- Current share price for EYE : $0.135

ASX company news and announcements for Nova Eye Medical Limited (EYE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nova Eye Medical Limited (EYE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nova Eye Medical Limited (EYE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nova Eye Medical Limited (EYE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Notification regarding unquoted securities - EYE 22 Jul 2025 12:47PM $0.150 $0.135 fallen by 10%
$38 Application for quotation of securities - EYE 22 Jul 2025 12:41PM $0.150 $0.135 fallen by 10%
$38 Investor Webinar 8 Jul 2025 10:26AM $0.145 $0.135 fallen by 6.90%
$38 Record Revenues for FY25 8 Jul 2025 9:56AM $0.125 $0.135 risen by 8%
$38 Investor Webinar Wednesday 9 July @ 11.30 am AEST 4 Jul 2025 10:19AM $0.120 $0.135 risen by 12.50%
$38 Notification of cessation of securities - EYE 20 Jun 2025 12:49PM $0.110 $0.135 risen by 22.73%
$38 Notification of cessation of securities - EYE 21 May 2025 1:51PM $0.125 $0.135 risen by 8%
$38 Application for quotation of securities - EYE 9 May 2025 10:44AM $0.125 $0.135 risen by 8%
$38 March Quarterly Webinar Presentation 6 May 2025 1:30PM $0.105 $0.135 risen by 28.57%
$38 Cleansing Notice 5 May 2025 11:39AM $0.110 $0.135 risen by 22.73%
$38 Application for quotation of securities - EYE 5 May 2025 11:36AM $0.110 $0.135 risen by 22.73%
$38 Notification of cessation of securities - EYE 2 May 2025 1:12PM $0.110 $0.135 risen by 22.73%
$38 Investor Webinar Tuesday 6 May @2.30 PM AEST 30 Apr 2025 2:08PM $0.110 $0.135 risen by 22.73%
$38 March 2025 Quarterly Activities Report and Appendix 4C 29 Apr 2025 9:59AM $0.099 $0.135 risen by 36.36%
$38 Application for quotation of securities - EYE 28 Mar 2025 3:28PM $0.100 $0.135 risen by 35%
$38 Change of Director's Interest Notice 28 Mar 2025 12:11PM $0.100 $0.135 risen by 35%
$38 Change in substantial shareholding from AEF 27 Mar 2025 2:15PM $0.095 $0.135 risen by 42.11%
$38 Application for quotation of securities - EYE 25 Mar 2025 12:02PM $0.100 $0.135 risen by 35%
$38 Cleansing Notice 25 Mar 2025 12:00PM $0.100 $0.135 risen by 35%
$38 EYE 19 March 2025 General Meeting Results 19 Mar 2025 5:05PM $0.105 $0.135 risen by 28.57%
$38 Investor Webinar 4 Mar 2025 10:59AM $0.105 $0.135 risen by 28.57%
$38 Presentation Half- Year Financial Report 26 Feb 2025 9:13AM $0.120 $0.135 risen by 12.50%
$38 Half-Year Report Release 26 Feb 2025 9:12AM $0.120 $0.135 risen by 12.50%
$38 Half Yearly Report and Accounts 26 Feb 2025 9:12AM $0.120 $0.135 risen by 12.50%
$38 Notice of General Meeting/Proxy Form 14 Feb 2025 3:02PM $0.130 $0.135 risen by 3.85%

51 - 75 of 349 results

Page 3 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.